The head of the main pharmaceutical industry lobbying group on Thursday warned that a bill to lower drug prices from Speaker Nancy Pelosi (D-Calif.) would have a “devastating” effect on the industry and weaken its ability to develop new treatments.
The head of the main pharmaceutical industry lobbying group on Thursday warned that a bill to lower drug prices from Speaker Nancy Pelosi (D-Calif.) would have a “devastating” effect on the industry and weaken its ability to develop new treatments.